Skip to content

On this page

Empliciti

elotuzumab

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Empliciti

Proper name

elotuzumab

Licence type

351(a)

BLA number

761035

Applicant

Bristol-Myers Squibb Company

Center

CDER

Presentations

2

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
300MG	For Injection	Intravenous	Single-Dose Vial	Rx	November 30, 2015
400MG	For Injection	Intravenous	Single-Dose Vial	Rx	November 30, 2015

Exclusivity

Source: Purple Book

Kind	Expires
Orphan exclusivity	November 6, 2025

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity